Peptide

Bonomarlot

Also known as

Bonomarlot peptide · bone-marrow bioregulator

Community talk. May contain inaccuracies. Not medical advice. Not a protocol. Not for human or animal use.

What it is

Identity	A bone-marrow bioregulator made from animal-marrow peptide fractions, rather than one defined peptide.
Forms discussed	Personal reports concern oral capsules. The separately marketed under-tongue liquid cannot be converted from capsule counts to drops.

Notes

An animal-marrow mixture. Bonomarlot's A-20 complex contains peptide fractions extracted from animal marrow. It is a mixture rather than one molecule with a single known absorption or clearance profile. Developer-linked clinical research brochure: Bonomarlot (Official context · Accessed 2026-09-30)

Cytomax means an extract. The community list distinguishes extracts from synthesized Cytogen peptides. Bonomarlot is not one defined peptide. Its organ name describes the proposed target; it does not demonstrate that swallowed material reaches the marrow intact. A List of Peptides and Their Corresponding Effects (Secondhand community claim · Accessed 2026-09-30)

Capsules and under-tongue liquid differ. The personal accounts concern oral capsules. Bonomarlot Lingual is a separately marketed liquid held under the tongue; capsule counts cannot be converted into drops. These reports do not establish an injectable formulation. Peptid.ru Bonomarlot Lingual (Official context · Accessed 2026-09-30) · Jepps reports long-term Bonomarlot capsule use (Personal report · Accessed 2026-09-30) · We tried 40 peptides in 1 year – our reviews and top picks! (Personal report · Accessed 2026-09-30)

Source context — Developer-linked clinical research brochure: Bonomarlot: Developer report in promotional brochure, not independent replication; no randomization/blinding stated in inspected passage. Cannot establish community dosing, human half-life, universal response, cancer treatment or long-term safety.

Source context — A List of Peptides and Their Corresponding Effects: Secondhand list, not a personal report. Broad claim that Russian trials were all injectable is contradicted by the inspected oral product report and is not adopted.

Source context — Peptid.ru Bonomarlot Lingual: Commercial Russian page; confirms marketed liquid form, not comparative absorption/effectiveness. Disease/cancer claims and universal stacking assurances are not adopted.

Source context — Jepps reports long-term Bonomarlot capsule use: One retrospective account; capsule strength, laboratory units, concurrent iron use and product identity not supplied. Quoted IV-every-2–3-months history belongs to Hoosierfans, not jepps. No controlled comparison or per-dose clock.

Source context — We tried 40 peptides in 1 year – our reviews and top picks!: Personal recovery blog with purchase links and coupon; major simultaneous changes, no verified Bonomarlot capsule strength, no isolated onset or effect duration.

What people notice

Blood-marker report	One user reported higher ferritin and hemoglobin during alternate-day capsule use after earlier iron treatments disappointed them. This is a lab self-report, not an immediate feeling.
Dizziness report	A blogger reported less dizziness after adding Bonomarlot, a kidney bioregulator and vinpocetine while already taking iron and another bioregulator. The account cannot identify which addition helped.

Notes

One long-term capsule user reports improved ferritin and hemoglobin after earlier iron treatments disappointed them. This is a lab self-report, not a known immediate feeling. Phoenix Rising post mentioning long-term Bonomarlot use (Personal report · Accessed 2026-09-22)

Low iron-related markers. One user reported higher ferritin (an iron-store marker) and hemoglobin (the oxygen-carrying blood protein) after disappointing iron treatments. The cause is uncertain. Jepps reports long-term Bonomarlot capsule use (Personal report · Accessed 2026-09-30)

One blood-test story, with missing units. In 2021, jepps reported ferritin rising from 10–15 to 100–110 and hemoglobin from 11–12 to 14–15 during ongoing use. Units and concurrent treatment were unspecified. The nearby repeated-infusion story belongs to another commenter, not this author. Jepps reports long-term Bonomarlot capsule use (Personal report · Accessed 2026-09-30)

Less lightheadedness. A recovery blogger described dizziness relief after several additions together. Other unlinked discussion uses milder comfort or recovery language. Neither establishes a predictable Bonomarlot feeling or a treatment for every cause of dizziness. We tried 40 peptides in 1 year – our reviews and top picks! (Personal report · Accessed 2026-09-30)

Dizziness relief came with several additions. The blogger was already using iron and a blood-vessel bioregulator, then added Bonomarlot, a kidney bioregulator and 5 mg morning vinpocetine. The page contains commercial links. Relief is the author's report; increased blood volume was their interpretation. We tried 40 peptides in 1 year – our reviews and top picks! (Personal report · Accessed 2026-09-30)

Source context — Phoenix Rising post mentioning long-term Bonomarlot use: Single retrospective self-report inside a thread about another treatment; unverified product, no controls and substantial medical-treatment context.

Doses people talk about

Alternate-day account	One oral capsule every second day; capsule strength was not given, so no milligram total can be assigned.
Mixed-stack account	One-quarter capsule, without a separate frequency or verified strength. The kidney product's daily wording does not establish Bonomarlot's daily amount.
Chart and seller context	A chart repeats 10–20 mg daily from manufacturer guidance. One seller lists two capsules totaling 20 mg active complex daily; these are commercial directions, not a tested community range.

Notes

One capsule every second day. This was jepps's oral pattern, not daily use. The post gives no capsule strength, so its amount cannot be converted to milligrams. Jepps reports long-term Bonomarlot capsule use (Personal report · Accessed 2026-09-30)

One-quarter capsule in a mixed stack. The blogger gives this Bonomarlot amount without a separate frequency or verified strength. The adjacent kidney entry's quarter-capsule-per-day wording does not establish Bonomarlot's daily total. We tried 40 peptides in 1 year – our reviews and top picks! (Personal report · Accessed 2026-09-30)

A chart repeats 10–20 mg per day. PeptideDosage describes one to two oral capsules and says its figures reflect manufacturer guidance. This is a label-derived daily total repeated in a biohacking chart, not a community-tested range. Capsule strength varies by product. Bonomarlot Dosage Chart, Schedule & Reconstitution Protocol (Community guide · Accessed 2026-09-30)

Seller directions are separate. Peptides Bulgaria lists two capsules totaling 20 mg active complex daily before meals for 30–60 days. That commercial course differs from the personal reports above; total capsule weight includes fillers and is not active peptide mass. Peptides Bulgaria Bonomarlot product description (Official context · Accessed 2026-09-30)

Source context — Bonomarlot Dosage Chart, Schedule & Reconstitution Protocol: Unverified secondary biohacking chart with template contradictions; not a measured human half-life or a firsthand user regimen. Injection/reconstitution directions rejected.

Source context — Peptides Bulgaria Bonomarlot product description: Commercial label claims only. Page lists inconsistent gross capsule weights (0.2 g and 0.275 g), distinct from active extract mass; tolerability wording cannot establish safety.

Half-life, onset & duration

Felt onset	No dependable single-dose onset is described. Unlinked notes mention stomach or mood changes in days 1–7, without a traceable timed account.
Felt duration	Not established. The two-year account describes ongoing use, not a two-year effect from one capsule.
Half-life	No measured human half-life is identified for this mixture. The chart's minutes estimate is extrapolated from other short peptides.

Notes

No dependable hours-or-days answer. Neither personal account clocks the first effect after a capsule. A later blood-test result and relief during a stack cannot supply a single-dose onset.

First-week changes are unverified. Unlinked oral discussion mentions stomach or mood changes in days 1–7. There is no identifiable author or frequency estimate, so this is a possible experience to keep distinct from a proven benefit window.

Single-dose duration remains unknown. The accounts do not say when a noticeable effect wears off or what persists after stopping. The two-year blood-marker account describes ongoing use, not a two-year effect from one dose.

No measured human half-life identified. The unlinked discussion has no product-specific human measurement. A mixture also need not have one shared disappearance time for all its components.

“Minutes” is a speculative category claim. PeptideDosage extrapolates from short peptides generally. It does not measure oral Bonomarlot in people; its longer gene-effect story does not validate the estimate. Bonomarlot Dosage Chart, Schedule & Reconstitution Protocol (Community guide · Accessed 2026-09-30)

Cycles people discuss

Long-term account	One user described alternate-day use for about two years; that does not establish long-term safety.
Short-course discussion	Unlinked category notes describe 10–20 days a few times yearly. A manufacturer-derived chart instead gives 20–30 days and 10-day pulses every 2–3 months; a seller gives 30–60 days.

Notes

About two years of alternate-day use. That one personal pattern differs sharply from short-course bioregulator culture. It does not establish that prolonged use is safe or necessary. Jepps reports long-term Bonomarlot capsule use (Personal report · Accessed 2026-09-30)

Short-course patterns come from different origins. Unlinked category discussion describes 10–20-day courses repeated a few times yearly. PeptideDosage repeats a 20–30-day course with 10-day pulses every 2–3 months from manufacturer-style guidance. Neither establishes a Bonomarlot community standard. Bonomarlot Dosage Chart, Schedule & Reconstitution Protocol (Community guide · Accessed 2026-09-30)

Stacks

Reported combination	The dizziness account combined Bonomarlot with iron, a vessel bioregulator, a kidney bioregulator and morning vinpocetine.
Proposed combination	A forum contributor proposed use after fasting-mimicking cycles and alongside Vesugen, while questioning the marrow-reserve theory. This was a proposal, not a successful regimen.

Notes

Marrow-reserve enthusiasm meets uncertainty. A LongeCity contributor proposed Bonomarlot after fasting-mimicking cycles and alongside Vesugen, but wondered whether stimulating marrow would expend reserves rather than enlarge them. This is an unresolved hypothesis, not a demonstrated danger or successful regimen. Stem cell self-renewal with C60 (Community opinion · Accessed 2026-09-30)

Source context — Stem cell self-renewal with C60: Speculative opinion, not an actual Bonomarlot response or established stem-cell risk; no Bonomarlot dose supplied.

Watch for

Blood-count claims	A low-iron-marker account does not establish benefit for high iron or high red-cell counts. Persistent dizziness and abnormal blood results need medical evaluation.
Mixture and safety	Animal origin, allergy and uncertain impurities matter; long-term safety and interactions remain unresolved. The developer excludes pregnancy and breastfeeding.
Capsule handling	Capsules are not injection material. Generic injection charts do not establish an injectable Bonomarlot route.

Notes

Normalizing blood counts is a claim. Marketing invokes excess red cells, immunity and cancer. A low-marker account cannot establish benefit for high iron or high red-cell counts. Blood abnormalities and persistent dizziness need medical evaluation. We tried 40 peptides in 1 year – our reviews and top picks! (Personal report · Accessed 2026-09-30)

Mixtures and stacks complicate safety. Animal origin, capsule ingredients, allergy and uncertain impurities matter. Long-term safety and drug interactions are unresolved; a favorable multi-product account cannot identify which component helped or caused a reaction.

Pregnancy and breastfeeding are cautions. Both are developer-listed exclusions. Developer-linked clinical research brochure: Bonomarlot (Official context · Accessed 2026-09-30)

Capsules are not injection material. Generic injection-site warnings in older discussion do not establish a Bonomarlot injection route. The chart's injection model must not be treated as an oral-product preparation method. Bonomarlot Dosage Chart, Schedule & Reconstitution Protocol (Community guide · Accessed 2026-09-30)

Full notes

Bonomarlot is a bone-marrow bioregulator discussed as an oral capsule. People look it up for low iron-related blood markers, dizziness and marrow support. A few favorable accounts exist, but neither a dependable felt effect nor a standard community schedule is established.

What Bonomarlot actually is

An animal-marrow mixture. Bonomarlot's A-20 complex contains peptide fractions extracted from animal marrow. It is a mixture rather than one molecule with a single known absorption or clearance profile. Official context
Cytomax means an extract. The community list distinguishes extracts from synthesized Cytogen peptides. Bonomarlot is not one defined peptide. Its organ name describes the proposed target; it does not demonstrate that swallowed material reaches the marrow intact. LongeCity
Capsules and under-tongue liquid differ. The personal accounts concern oral capsules. Bonomarlot Lingual is a separately marketed liquid held under the tongue; capsule counts cannot be converted into drops. These reports do not establish an injectable formulation. Official context Personal report Personal report
Blood support is the appeal. Bioregulator discussions describe restoring organ function, while longevity enthusiasts speculate about marrow reserves. That story is different from an immediate stimulant feeling, and it does not demonstrate immune rejuvenation. Community LongeCity

What people hope to improve

Low iron-related markers. One user reported higher ferritin (an iron-store marker) and hemoglobin (the oxygen-carrying blood protein) after disappointing iron treatments. The cause is uncertain. Personal report
Less lightheadedness. A recovery blogger described dizziness relief after several additions together. Other unlinked discussion uses milder comfort or recovery language. Neither establishes a predictable Bonomarlot feeling or a treatment for every cause of dizziness. Personal report Community

Doses people discuss

One capsule every second day. This was jepps's oral pattern, not daily use. The post gives no capsule strength, so its amount cannot be converted to milligrams. Personal report
One-quarter capsule in a mixed stack. The blogger gives this Bonomarlot amount without a separate frequency or verified strength. The adjacent kidney entry's quarter-capsule-per-day wording does not establish Bonomarlot's daily total. Personal report
A chart repeats 10–20 mg per day. PeptideDosage describes one to two oral capsules and says its figures reflect manufacturer guidance. This is a label-derived daily total repeated in a biohacking chart, not a community-tested range. Capsule strength varies by product. Community guide

Half-life

No measured human half-life identified. The unlinked discussion has no product-specific human measurement. A mixture also need not have one shared disappearance time for all its components. Community
“Minutes” is a speculative category claim. PeptideDosage extrapolates from short peptides generally. It does not measure oral Bonomarlot in people; its longer gene-effect story does not validate the estimate. Community guide

When people notice a change

No dependable hours-or-days answer. Neither personal account clocks the first effect after a capsule. A later blood-test result and relief during a stack cannot supply a single-dose onset. Community
First-week changes are unverified. Unlinked oral discussion mentions stomach or mood changes in days 1–7. There is no identifiable author or frequency estimate, so this is a possible experience to keep distinct from a proven benefit window. Community

How long an effect lasts

Single-dose duration remains unknown. The accounts do not say when a noticeable effect wears off or what persists after stopping. The two-year blood-marker account describes ongoing use, not a two-year effect from one dose. Community

Courses and breaks

About two years of alternate-day use. That one personal pattern differs sharply from short-course bioregulator culture. It does not establish that prolonged use is safe or necessary. Personal report
Short-course patterns come from different origins. Unlinked category discussion describes 10–20-day courses repeated a few times yearly. PeptideDosage repeats a 20–30-day course with 10-day pulses every 2–3 months from manufacturer-style guidance. Neither establishes a Bonomarlot community standard. Community Community guide

Good to know

Normalizing blood counts is a claim. Marketing invokes excess red cells, immunity and cancer. A low-marker account cannot establish benefit for high iron or high red-cell counts. Blood abnormalities and persistent dizziness need medical evaluation. Personal report Community
Mixtures and stacks complicate safety. Animal origin, capsule ingredients, allergy and uncertain impurities matter. Long-term safety and drug interactions are unresolved; a favorable multi-product account cannot identify which component helped or caused a reaction. Community
Pregnancy and breastfeeding are cautions. Both are developer-listed exclusions. Official context
Severe symptoms require urgent care. Severe allergic symptoms, chest pain or new neurological changes need medical attention, rather than reassurance from supplement reports. Community
Capsules are not injection material. Generic injection-site warnings in older discussion do not establish a Bonomarlot injection route. The chart's injection model must not be treated as an oral-product preparation method. Community guide Community

What the community accounts add

One blood-test story, with missing units. In 2021, jepps reported ferritin rising from 10–15 to 100–110 and hemoglobin from 11–12 to 14–15 during ongoing use. Units and concurrent treatment were unspecified. The nearby repeated-infusion story belongs to another commenter, not this author. Personal report
Dizziness relief came with several additions. The blogger was already using iron and a blood-vessel bioregulator, then added Bonomarlot, a kidney bioregulator and 5 mg morning vinpocetine. The page contains commercial links. Relief is the author's report; increased blood volume was their interpretation. Personal report
Marrow-reserve enthusiasm meets uncertainty. A LongeCity contributor proposed Bonomarlot after fasting-mimicking cycles and alongside Vesugen, but wondered whether stimulating marrow would expend reserves rather than enlarge them. This is an unresolved hypothesis, not a demonstrated danger or successful regimen. LongeCity

Product evidence and label context

A small developer report. The developer brochure describes Bonomarlot added to conventional anemia care, with a conventional-care comparison group. It does not establish a standalone benefit, and the inspected passage states no randomization or blinding. Official context
Seller directions are separate. Peptides Bulgaria lists two capsules totaling 20 mg active complex daily before meals for 30–60 days. That commercial course differs from the personal reports above; total capsule weight includes fillers and is not active peptide mass. Official context